Ethyl 2-[(2S)-2-(1,1-difluoropropoxymethyl)-4-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]pyrimidine-5-carboxylate
C22H24F5N3O3 — CID 156694659
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-[(2S)-2-(1,1-difluoropropoxymethyl)-4-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]pyrimidine-5-carboxylate
Ethyl 2-[(2S)-2-(1,1-difluoropropoxymethyl)-4-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]pyrimidine-5-carboxylate (PubChem CID 156694659) has the molecular formula C22H24F5N3O3 and a molecular weight of 473.44 g/mol. Its IUPAC name is ethyl 2-[(2S)-2-(1,1-difluoropropoxymethyl)-4-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]pyrimidine-5-carboxylate.
Molecular Properties
| Compound Name | Ethyl 2-[(2S)-2-(1,1-difluoropropoxymethyl)-4-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]pyrimidine-5-carboxylate |
|---|---|
| PubChem CID | 156694659 |
| Molecular Formula | C22H24F5N3O3 |
| Molecular Weight | 473.44 g/mol |
| Exact Mass | 473.17 |
| IUPAC Name | ethyl 2-[(2S)-2-(1,1-difluoropropoxymethyl)-4-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]pyrimidine-5-carboxylate |
| SMILES | CCOC(=O)c1cnc(N2CC(c3ccc(C(F)(F)F)cc3)C[C@H]2COC(F)(F)CC)nc1 |
| InChI | InChI=1S/C22H24F5N3O3/c1-3-21(23,24)33-13-18-9-15(14-5-7-17(8-6-14)22(25,26)27)12-30(18)20-28-10-16(11-29-20)19(31)32-4-2/h5-8,10-11,15,18H,3-4,9,12-13H2,1-2H3/t15?,18-/m0/s1 |
| InChIKey | NUHQHIIICBAKBC-PKHIMPSTSA-N |
| XLogP | 5.05 |
| TPSA | 64.55 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 473.44 |
| LogP ≤ 5 | 5.05 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156694659 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.